La personas que padecen sida tienen mayor probabilidad de contraer hepatitis C o B. En estas personas, además, dichas infecciones progresan de manera acelerada y provocan complicaciones con más facilidad. Estudios recientes profundizan en esta relación:
The 2013 Short Guide to Hepatitis C. Flying Publisher. Books
A brighter future in the fight against hepatitis. Nature Medicine 19, 791 (2013)
Regulation of hepatic innate immunity by hepatitis C virus. Nature Medicine 19, 879–888 (2013)
Current progress in development of hepatitis C virus vaccines. Nature Medicine 19, 869-878 (2013)
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nature Medicine 19, 859-868 (2013)
Global control of hepatitis C: where challenge meets opportunity. Nature Medicine 19, 850-858 (2013)
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nature Medicine 19, 837-849 (2013)
Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B. Journal of clinical oncology. Published Ahead of Print on June 17, 2013
British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010. HIV Medicine (2010), 11 , 1–30. En DynaMed
Viral hepatitis in HIV infection. The New England Journal Of Medicine [N Engl J Med] 2007 Apr 5; Vol. 356 (14), pp. 1445-54. En DynaMed
